EZH2 and non-small cell lung carcinoma: found that the nucleus-localized LINC01133 could interact with EZH2 and LSD1 and repress the transcription of KLF2, P21, or E-cadherin by recruiting EZH2 and LSD1 to the promoter regions of the inhibited genes in non-small cell lung cancer (33).